Funded Tech Companies

Orexigen Therapeutics

Wondering who provided funding to Orexigen Therapeutics? Private investors, Morgenthaler Ventures and EPIC Ventures invested in this biopharmaceutical company.

Company Overview

Contact Information

Company Background Information

Overview

OREXIGEN is studying a novel, and potentially more effective way, to achieve and sustain weight loss through a combined, two-drug approach.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

3/4/2017

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Michael Narachi

        

Chief Financial Officer

Monica Forbes

        

Chief Operating Officer

Thomas Cannell

        

VP - Bus. Development

Peter Flynn

        

VP - General Counsel

Thomas Lynch

        

Company Investors

• Morgenthaler Ventures
• EPIC Ventures
• Domain Associates
• Scale Venture Partners
• MPM Capital
• Kleiner Perkins Caufield & Byers
• Montreux Equity Partners
• Sofinnova Ventures
• Domain Associates (Eckard Weber)
• Scale Venture Partners (Louis Bock)
• Kleiner Perkins Caufield & Byers (Joseph Lacob)
• Montreux Equity Partners (Daniel Turner)
• Sofinnova Ventures (Michael Powell)

Browse more funded tech companies:

Oreon | Organ Transport Systems

Share this article

About Our VC Funding Database

This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary